From the plant
to the pill.
Malana Organics is building India's first fully integrated medical-cannabis supply chain — licensed research, organic Himalayan cultivation, pharma-grade extraction and export. One plant, taken responsibly from soil to standardised medicine.
A plant India has always known — legal to study once more.
Cannabis is woven through the subcontinent's history. The Atharva Veda names it among five sacred plants; for centuries it lived in Ayurvedic pharmacopoeia and in the terraced valleys of Himachal, where the Malana strain became known the world over. In 2026, Himachal Pradesh reopened the door — legalising controlled cultivation and research of medical cannabis. Malana Organics exists to meet that moment with rigour, not romance.
The same soil, the same plant — held now to the standard of medicine. Malana Valley · 2,652 m · Kullu, Himachal Pradesh
One plant. Dozens of molecules. A field of medicine still being read.
Cannabis produces more than a hundred cannabinoids — compounds the human body already has receptors for, through the endocannabinoid system that helps regulate sleep, appetite, pain signalling and mood. Modern medicine studies these molecules individually and in combination. Our work begins where that science does: isolating, standardising and characterising each compound to pharmaceutical precision.
Cannabidiol
Non-intoxicating and the most-studied cannabinoid in medicine. The backbone of most pharmaceutical and nutraceutical formulations.
Tetrahydrocannabinol
A controlled, intoxicating compound handled strictly within licensed medical and research limits. Precisely measured, never promoted for recreation.
Cannabigerol
The "mother cannabinoid" from which others form. An emerging focus for research-grade extracts and specialised formulations.
Aromatic profile
The plant's aromatic compounds, preserved and profiled — a key part of characterising each cultivar for consistent, reproducible output.
Informational only. Nothing on this page is a medical claim, and no product is offered for the diagnosis, treatment or cure of any condition. Cannabinoid products are supplied strictly to licensed partners for medical, research and industrial use.
Plant to pill, under one roof.
Most of the value — and all of the risk — in cannabis sits in the gaps between growing, extracting and formulating. We hold the whole chain, so provenance and purity are never handed off.
Cultivar genetics, cannabinoid profiling and analytical method development — done first, so everything downstream is measured, not guessed. Partnerships with research institutions anchor the work in evidence.
Organic cultivation in the high-altitude Himalayan terroir that made this valley's plant famous. Licensed plots, controlled inputs, and a seed-to-harvest record for every batch.
Solvent-free and GMP-aligned extraction that separates cannabinoids and terpenes cleanly, then standardises them to exact potency. Every output is lab-verified before it moves.
Isolates, full-spectrum extracts, active ingredients and finished formulations — oils, capsules, nutraceuticals and research material — manufactured to consistent pharmaceutical specification.
Licensed B2B supply to pharmaceutical manufacturers, formulators and research institutions in India, and export to regulated international markets — each shipment fully documented and compliant.
A catalogue built for formulators, not shelves.
We supply the inputs and finished goods that licensed partners build on — standardised, documented and export-grade.
Isolates & APIs
High-purity CBD, CBG and other single-molecule actives, characterised to pharmaceutical specification for manufacturing.
Full-spectrum extracts
Standardised oils and distillates that preserve the plant's cannabinoid and terpene profile at controlled ratios.
Formulations
Capsules, oils and topicals produced to consistent dose and specification for licensed medical and nutraceutical partners.
Research material
Reference standards and characterised compounds supplied to academic and institutional research programmes.
Nutraceuticals
Wellness-grade hemp and CBD inputs for compliant nutraceutical lines, within permitted limits.
Export SKUs
Documentation-ready product for regulated international markets, with full provenance and testing records.
Pharma-grade standards at every gate.
Cannabis earns trust the way any medicine does — through documentation, testing and control. Nothing leaves a stage without clearing it.
Licensed & compliant
Cultivation, processing and supply conducted under the Himachal Pradesh medical-cannabis framework, with all permits in order.
Seed-to-sale traceability
Every batch carries an unbroken record from plot to shipment — genetics, inputs, potency and chain of custody.
Independent lab testing
Third-party assays for potency, pesticides, heavy metals and microbials — results attached to every lot.
GMP-aligned facilities
Extraction and manufacturing built to good-manufacturing-practice standards, with export documentation in mind from day one.
Built for the licensed few.
Malana Organics supplies businesses and institutions that hold a valid purchase licence. If that's you, we'd like to talk.
India is writing the rules for a plant it once wrote poems about.
Himachal's medical-cannabis framework is the first chapter of a regulated Indian industry — one that can serve patients, fund research and earn export revenue. Malana Organics intends to be the player that does it properly: transparent, science-first, and built to the standard the plant has finally been given.
The questions worth asking.
Yes. In 2026 Himachal Pradesh legalised the controlled cultivation and research of medical cannabis. Malana Organics operates entirely within that framework, with the required licences for cultivation, processing and supply, and works only with partners who hold a valid purchase licence.
No. Our work is strictly medical, research and industrial. We supply licensed pharmaceutical manufacturers, formulators and research institutions — not consumers — and we make no recreational claims. Controlled compounds such as THC are handled only within permitted medical and research limits.
Both are cannabinoids the plant produces. CBD is non-intoxicating and is the basis of most medical and nutraceutical formulations. THC is intoxicating and tightly controlled; where it appears in a product it is precisely measured and supplied only under licence for medical or research use.
No. Malana Organics is a business-to-business and research supplier. Products are provided to organisations and institutions that hold the appropriate licence for medical, research or industrial use.
Because we hold the whole chain — research, cultivation, extraction, production and export — rather than handing off between stages. That's how provenance and pharmaceutical purity are protected end to end, and how a batch stays traceable from a Himalayan plot to a finished, documented product.
Bring the whole plant to your formulation.
If you hold a licence to research, manufacture or formulate with cannabis, let's build a supply relationship you can trust — traceable, standardised and export-ready.